HMN CEO Marita Zuraitis sold 69,925 shares for $2.9M across 6 transactions (Nov 7-11) at $41.48 blended average.
Marita Zuraitis, HMN President & CEO, executed 6 separate sales totaling 69,925 shares for $2,900,306.52 ($2.9M) at a blended average price of $41.48 between November 7 and 11, 2024, reducing her holdings by 18.7% from 374,466 to 304,541 shares. The sale occurred near the 52-week high of $42.64 (-1.4%) and follows strong recent momentum: the stock gained 20.6% over 30 days and 25.8% over 90 days. The magnitude of this equity reduction by the CEO—nearly 70K shares—is material in absolute terms and represents a significant portfolio adjustment. Critically, Zuraitis's cross-ticker track record shows poor sell timing overall: her 6 prior open-market sells posted an average 90-day return of -1.0% (well-timed rate 100.00%, meaning those sells preceded declines); however, at HMN specifically, her 2 measurable prior sells (January 2024) achieved -0.8% and -1.1% 90-day returns, while 3 more recent October sells are not yet measurable. The stock's fundamentals remain solid (P/E 16.49, $1.7B market cap, 7.9% revenue growth), but the timing of a large CEO equity reduction following a steep recent rally warrants investor attention.